cobalt has been researched along with Sclerosis, Systemic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allanore, Y; Borderie, D; Devaux, JY; Ekindjian, OG; Kahan, A; Meune, C | 1 |
Cho, CS; Choi, JJ; Hong, KH; Kang, SS; Kim, WU; Yoo, SA | 1 |
Panasiuk, J | 1 |
3 other study(ies) available for cobalt and Sclerosis, Systemic
Article | Year |
---|---|
High ischemia-modified albumin concentration reflects oxidative stress but not myocardial involvement in systemic sclerosis.
Topics: Albumins; Biomarkers; Cobalt; Female; Humans; Male; Myocardial Ischemia; Oxidative Stress; Protein Binding; Scleroderma, Systemic | 2004 |
Hypoxia induces expression of connective tissue growth factor in scleroderma skin fibroblasts.
Topics: Cell Hypoxia; Cells, Cultured; Cobalt; Connective Tissue Growth Factor; Fibroblasts; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; NF-kappa B; RNA, Messenger; Scleroderma, Systemic; Signal Transduction; Skin; Transfection; Transforming Growth Factor beta; Up-Regulation | 2006 |
[Peripheral blood lymphocyte transformation test in various skin diseases of allergic origin].
Topics: Autoimmune Diseases; Cobalt; Dermatitis, Contact; Erythema Nodosum; Humans; Hypersensitivity, Delayed; In Vitro Techniques; Lupus Erythematosus, Systemic; Lymphocyte Activation; Nickel; Scleroderma, Systemic; Skin Diseases; T-Lymphocytes; Tuberculosis, Cutaneous | 1980 |